Patrick Chaftari

Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Patrick Chaftari is a faculty member at The University of Texas MD Anderson Cancer Center in the United States. His research primarily focuses on the diagnosis and treatment of invasive aspergillosis in cancer patients, as well as the management of complications related to cancer treatments. Recent publications include analyses of serum biomarkers, outcomes of antifungal prophylaxis, and the impact of immune checkpoint inhibitors on patients. He is actively involved in studies addressing emergency care for cancer patients with varying complications.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Collaborators (6)

Demis Lipe

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Anne-Marie Chaftari

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Aiham Qdaisat

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Ziyi Li

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Teny M John

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Cielito Reyes-Gibby

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patrick Chaftari

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Prognostic Value of Serum and Bronchoalveolar Lavage Fluid Galactomannan Levels in Invasive Aspergillosis: An 8-Year Experience at a Tertiary Cancer Center

Outcome Analysis of Breakthrough Invasive Aspergillosis on Anti-Mold Azole Prophylaxis and Treatment: 30-Year Experience in Hematologic Malignancy Patients

Decreased Frequency and Improved Outcomes in Invasive Aspergillosis Caused by Aspergillus terreus After the Introduction of Anti-Mold Azole Agents: A 30-Year Study at a Tertiary Cancer Center

Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review

Severity of Symptoms as an Independent Predictor of Poor Outcomes in Patients with Advanced Cancer Presenting to the Emergency Department: Secondary Analysis of a Prospective Randomized Study

Procalcitonin Level Monitoring in Antibiotic De-Escalation and Stewardship Program for Patients with Cancer and Febrile Neutropenia

Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management

Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients

Hemoptysis in Cancer Patients

Characteristics and Outcomes of Patients with Cancer Pain Placed in an Emergency Department Observation Unit

Collaborators (6)

Demis Lipe

Anne-Marie Chaftari

Aiham Qdaisat

Ziyi Li

Teny M John

Cielito Reyes-Gibby

Make your next move.